Clinical Practice

Use the tool below to view all available Global Cardiology Academy Series

Optimizing Outcomes in Patients With oHCM: The Emerging Role of Cardiac Myosin Inhibitors
Optimizing Outcomes in Patients With oHCM: The Emerging Role of Cardiac Myosin Inhibitors
CME/CE Broadcast Replay
Optimizing Outcomes in Patients With oHCM: The Emerging Role of Cardiac Myosin Inhibitors
0.50 credits
- Iacopo Olivotto, MD
- Ahmad Masri, MD, MS
- Pablo Garcia-Pavia, MD, PhD
- Fabian Knebel, MD, PhD
- Caroline Coats, MD
0.50 credits
Understanding Lipid and Lipoprotein Metabolism in Cardiovascular Health
Understanding Lipid and Lipoprotein Metabolism in Cardiovascular Health
Heart Matters
Understanding Lipid and Lipoprotein Metabolism in Cardiovascular Health
EASD Highlights: Prediabetes Diagnosis, Prevalence, Misclassification Risks, and the Potential for Remission
EASD Highlights: Prediabetes Diagnosis, Prevalence, Misclassification Risks, and the Potential for Remission
Diabetes and Endocrinology
EASD Highlights: Prediabetes Diagnosis, Prevalence, Misclassification Risks, and the Potential for Remission
- Femke Rutters, MD
New Insights in the Management of HCM: Exploring the Clinical Spectrum
New Insights in the Management of HCM: Exploring the Clinical Spectrum
CME/CE Broadcast Replay
New Insights in the Management of HCM: Exploring the Clinical Spectrum
0.50 credits
- Milind Y. Desai, MD, MBA
- Iacopo Olivotto, MD
- Elena Arbelo, MD, PhD
0.50 credits
Managing Statin Intolerance: Practical Approaches and Emerging Non-Statin Options
Managing Statin Intolerance: Practical Approaches and Emerging Non-Statin Options
Heart Matters
Managing Statin Intolerance: Practical Approaches and Emerging Non-Statin Options
Improving Lipid Management Through Equity-Focused Clinical Strategies
Improving Lipid Management Through Equity-Focused Clinical Strategies
Heart Matters
Improving Lipid Management Through Equity-Focused Clinical Strategies
Integrating Lipoprotein(a) Into Cardiovascular Risk Assessment
Integrating Lipoprotein(a) Into Cardiovascular Risk Assessment
Heart Matters
Integrating Lipoprotein(a) Into Cardiovascular Risk Assessment
PCSK9 Inhibitors and Statins: Meta-Analysis Highlights Benefit of Combination Therapy
PCSK9 Inhibitors and Statins: Meta-Analysis Highlights Benefit of Combination Therapy
Heart Matters
PCSK9 Inhibitors and Statins: Meta-Analysis Highlights Benefit of Combination Therapy
Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
CME/CE
Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
- Daniel Judge, MD
Redefining HF Care: The Role of Finerenone in Patients With LVEF ≥40% 
Redefining HF Care: The Role of Finerenone in Patients With LVEF ≥40% 
Cardiology
Redefining HF Care: The Role of Finerenone in Patients With LVEF ≥40% 
- Javed Butler, MD
Addressing CKM Mortality & Morbidity in Patients With CKD and T2D: The Role of Combined ns-MRA & SGLT2i Therapy
Addressing CKM Mortality & Morbidity in Patients With CKD and T2D: The Role of Combined ns-MRA & SGLT2i Therapy
CME/CE
Addressing CKM Mortality & Morbidity in Patients With CKD and T2D: The Role of Combined ns-MRA & SGLT2i Therapy
0.50 credits
- Rajiv Agarwal, MBBS, MD, FASN, BRCU
- Amy Mottl, MD, MPH
- Muthiah Vaduganathan, MD, MPH
0.50 credits
TTR Levels and Associated Disease Risk: Insights from 2025 PNS Conference
TTR Levels and Associated Disease Risk: Insights from 2025 PNS Conference
CME/CE
TTR Levels and Associated Disease Risk: Insights from 2025 PNS Conference
- Ahmad Masri, MD, MS
Decoding COPD: Precision Medicine Approaches for Complex Patient Profiles
Decoding COPD: Precision Medicine Approaches for Complex Patient Profiles
Pulmonary Medicine
Decoding COPD: Precision Medicine Approaches for Complex Patient Profiles
- Matthew Moll, MD, MPH
The Future of Precision Medicine in COPD Care: Biomarkers, AI, and Multimodal Data
The Future of Precision Medicine in COPD Care: Biomarkers, AI, and Multimodal Data
Pulmonary Medicine
The Future of Precision Medicine in COPD Care: Biomarkers, AI, and Multimodal Data
- Matthew Moll, MD, MPH
ECG Markers as Predictors of Adverse Outcomes in COPD: Insights from the IMPACT Trial
ECG Markers as Predictors of Adverse Outcomes in COPD: Insights from the IMPACT Trial
Cardiology
ECG Markers as Predictors of Adverse Outcomes in COPD: Insights from the IMPACT Trial
- Raymond Wade, MD
Statins and Safety: What the Data Say About Dementia, Cancer, and More
Statins and Safety: What the Data Say About Dementia, Cancer, and More
MinuteCE®
Statins and Safety: What the Data Say About Dementia, Cancer, and More
1.00 program credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 program credit

Clinical Practice

Popular

Title

Share on ReachMD

Welcome to Global Cardiology Academy

Welcome to Global
Cardiology Academy